HGK Asset Management Inc. lowered its position in Kimberly Clark Corp (NYSE:KMB) by 11.0% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 38,704 shares of the company’s stock after selling 4,782 shares during the period. HGK Asset Management Inc.’s holdings in Kimberly Clark were worth $5,158,000 at the end of the most recent reporting period.

Several other hedge funds have also recently made changes to their positions in KMB. Horan Capital Advisors LLC. purchased a new stake in shares of Kimberly Clark in the first quarter valued at about $25,000. HMS Capital Management LLC purchased a new stake in Kimberly Clark during the second quarter worth about $28,000. Manchester Financial Inc. purchased a new stake in Kimberly Clark during the second quarter worth about $34,000. Weaver Consulting Group purchased a new stake in Kimberly Clark during the first quarter worth about $38,000. Finally, Penserra Capital Management LLC purchased a new stake in Kimberly Clark during the first quarter worth about $40,000. Institutional investors own 71.45% of the company’s stock.

Shares of KMB traded up $0.44 during trading hours on Monday, hitting $137.61. The company’s stock had a trading volume of 33,242 shares, compared to its average volume of 1,554,804. The company has a market cap of $47.21 billion, a P/E ratio of 20.79, a price-to-earnings-growth ratio of 3.67 and a beta of 0.58. The company has a current ratio of 0.81, a quick ratio of 0.53 and a debt-to-equity ratio of 134.02. The company has a 50 day moving average price of $136.29. Kimberly Clark Corp has a 52-week low of $100.32 and a 52-week high of $140.62.

Kimberly Clark (NYSE:KMB) last posted its earnings results on Tuesday, July 23rd. The company reported $1.67 earnings per share for the quarter, topping the consensus estimate of $1.64 by $0.03. The firm had revenue of $4.59 billion during the quarter, compared to the consensus estimate of $4.60 billion. Kimberly Clark had a net margin of 9.80% and a return on equity of 27,094.12%. The company’s revenue was down .2% on a year-over-year basis. During the same quarter last year, the company earned $1.59 earnings per share. As a group, sell-side analysts anticipate that Kimberly Clark Corp will post 6.8 EPS for the current year.

The firm also recently announced a quarterly dividend, which was paid on Tuesday, July 2nd. Stockholders of record on Friday, June 7th were paid a $1.03 dividend. The ex-dividend date was Thursday, June 6th. This represents a $4.12 annualized dividend and a dividend yield of 2.99%. Kimberly Clark’s payout ratio is 62.33%.

In other news, insider Kimberly K. Underhill sold 23,785 shares of the firm’s stock in a transaction that occurred on Wednesday, May 22nd. The shares were sold at an average price of $131.05, for a total value of $3,117,024.25. Following the completion of the transaction, the insider now directly owns 51,307 shares in the company, valued at $6,723,782.35. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, SVP Sandra Macquillan sold 5,385 shares of the firm’s stock in a transaction that occurred on Thursday, May 9th. The shares were sold at an average price of $126.15, for a total transaction of $679,317.75. Following the completion of the transaction, the senior vice president now owns 15,814 shares of the company’s stock, valued at $1,994,936.10. The disclosure for this sale can be found here. Insiders sold 135,961 shares of company stock valued at $17,442,674 in the last quarter. Corporate insiders own 0.85% of the company’s stock.

A number of research firms recently issued reports on KMB. Barclays restated a “hold” rating on shares of Kimberly Clark in a report on Sunday. Wells Fargo & Co restated a “hold” rating and set a $130.00 price objective on shares of Kimberly Clark in a report on Tuesday, July 23rd. JPMorgan Chase & Co. restated a “buy” rating on shares of SAGE Therapeutics in a report on Wednesday, July 24th. ValuEngine downgraded shares of Zumiez from a “hold” rating to a “sell” rating in a report on Monday, May 13th. Finally, Zacks Investment Research upgraded shares of Green Brick Partners from a “sell” rating to a “hold” rating in a report on Thursday, April 25th. Two investment analysts have rated the stock with a sell rating, eight have given a hold rating and seven have given a buy rating to the stock. The stock presently has a consensus rating of “Hold” and a consensus target price of $128.81.

Kimberly Clark Profile

Kimberly-Clark Corporation, together with its subsidiaries, manufactures and markets personal care, consumer tissue, and professional products worldwide. It operates through three segments: Personal Care, Consumer Tissue, and K-C Professional. The Personal Care segment offers disposable diapers, training and youth pants, swimpants, baby wipes, feminine and incontinence care products, and other related products under the Huggies, Pull-Ups, Little Swimmers, GoodNites, DryNites, Kotex, U by Kotex, Intimus, Depend, Plenitud, Poise, and other brand names.

Featured Article: Oversold

Institutional Ownership by Quarter for Kimberly Clark (NYSE:KMB)

Receive News & Ratings for Kimberly Clark Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kimberly Clark and related companies with MarketBeat.com's FREE daily email newsletter.